The role of MCP-1 in the developments of diabetic nephropathy in patients with type 2 diabetes mellitus patients

Al-karrar Kais abdul Jaleel Duaibel; Haider A. Alnaji; Ali Mohammed Hussein Abdulhadi; Abbas F. Almulla; Asmaa M. Mohammed AL-attraqchi; Inas Qasim Rahim

doi:10.53730/ijhs.v6nS2.7049

Authors

Al-karrar Kais abdul Jaleel Duaibel
Alkkais50@gmail.com
Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq
Haider A. Alnaji Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq & Biology Department, College of Science, Babylon University, Babylon, Iraq
Ali Mohammed Hussein Abdulhadi Alkafeel University, College of Medical Technologies, Najaf, Iraq
Abbas F. Almulla Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq & Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Asmaa M. Mohammed AL-attraqchi Middle-Euphrates-Neuroscience-Center in Al najaf Al-Ashraf/Iraq
Inas Qasim Rahim Al-Furat Al-Awsat Technical University, Medical Technology department, Najaf, Iraq

Keywords:

diabetic nephropathy, diabetes mellitus patients, MCP-1

Abstract

Several complications may be developed during infection with type 2 diabetes mellitus. One of the most is diabetic nephropathy, leading to end-stage renal disease in more than 30% of diabetes mellitus. Monocyte, which is derived from blood circulation to the tissue the maintains an inflammatory state. Several factors and chemokines regulate the activity of monocytes. One of them is Monocyte chemoattractant protein-1 (MCP-1) which is released by several adipocytes that help attract monocytes during inflammation. Patients and methods: the samples were collected from patients who attended diabetes and endocrinology center in Al-Sader Teaching Hospital in Najaf between January 2019 to April 2019. This study involves 300 subjects. One hundred fifty of them were diagnosed with type 2 diabetes mellitus. According to their albumin/creatinine ratio (ACR), these patients were classified into three groups, including 50 patients with severe nephropathy, 50 patients with moderate nephropathy, and 50 patients with mild nephropathy. The control group involved 150 subjects who appeared healthy and the same age as the patients' group. Result: a significant increase of MCP-1 level was found in patients with mild, moderate and severe diabetic patients compared with healthy control.

Downloads

Download data is not yet available.

References

Nguyen, V. Lynn, C., Shaw, Maria, B., Grant. (2012). Inflammation in the pathogenesis of microvascular complications in diabetes Dung. MINI REVIEW ARTICLE published: 21 December.

Soumya, D., & Srilatha, B. (2011). Late stage complications of diabetes and insulin resistance. J Diabetes Metab, 2(9), 1000167.‏

Hall, J. E. (2011). Guyton y Hall. Elsevier Health Sciences Spain.‏

American Diabetes Association. (2020). 15. Diabetes care in the hospital: standards of medical care in diabetes—2020. Diabetes Care, 43(Supplement 1), S193-S202.‏

Poretsky, L. (Ed.). (2010). Principles of diabetes mellitus (Vol. 21). Springer Science & Business Media.‏

Imani, P. D., Carpenter, J. L., Bell, C. S., Brandt, M. L., Braun, M. C., & Swartz, S. J. (2018). Peritoneal dialysis catheter outcomes in infants initiating peritoneal dialysis for end-stage renal disease. BMC nephrology, 19(1), 1-7.‏

Lopez-Giacoman, S., & Madero, M. (2015). Biomarkers in chronic kidney disease, from kidney function to kidney damage. World journal of nephrology, 4(1), 57.‏

Zhong, Z. X., Cui, Z. H., Li, X. J., Tang, T., Zheng, Z. J., Ni, W. N., ... & Sun, J. (2020). Nitrofurantoin combined with amikacin: A promising alternative strategy for combating MDR uropathogenic Escherichia coli. Frontiers in cellular and infection microbiology, 10, 811.‏

Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li, Q., Hirakawa, Y., ... & Woodward, M. (2014). Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. New England Journal of Medicine, 371(15), 1392-1406.‏

Futagami, S., Hiratsuka, T., Shindo, T., Hamamoto, T., Tatsuguchi, A., Nobue, U., ... & Sakamoto, C. (2008). COX-2 and CCR2 induced by CD40 ligand and MCP-1 are linked to VEGF production in endothelial cells. Prostaglandins, leukotrienes and essential fatty acids, 78(2), 137-146.‏

Montero, R. M., Covic, A., Gnudi, L., & Goldsmith, D. (2016). Diabetic nephropathy: What does the future hold?. International urology and nephrology, 48(1), 99-113.‏

Tam, F. W., Riser, B. L., Meeran, K., Rambow, J., Pusey, C. D., & Frankel, A. H. (2009). Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy. Cytokine, 47(1), 37-42.‏

Gharib, M. A. A. K., Bakrand, E. S. H., & Baz, S. M. (2016). Hypoglycemic efficacy of date kernels coffee on diabetic and nephrodiabetic patients. Life Science Journal, 13(4), 10-18.‏

Dhanya, R., Arya, A. D., Nisha, P., & Jayamurthy, P. (2017). Quercetin, a lead compound against type 2 diabetes ameliorates glucose uptake via AMPK pathway in skeletal muscle cell line. Frontiers in Pharmacology, 8, 336.‏

Kiritoshi, S., Nishikawa, T., Sonoda, K., Kukidome, D., Senokuchi, T., Matsuo, T., ... & Araki, E. (2003). Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes, 52(10), 2570-2577.‏

Grams, M. E., Sang, Y., Levey, A. S., Matsushita, K., Ballew, S., Chang, A. R., ... & Garg, A. X. (2016). Kidney-failure risk projection for the living kidney-donor candidate. New England Journal of Medicine, 374(5), 411-421.‏

Wang, S. Y., Zang, X. Y., Fu, S. H., Bai, J., Liu, J. D., Tian, L., ... & Zhao, Y. (2016). Factors related to fatigue in Chinese patients with end-stage renal disease receiving maintenance hemodialysis: a multi-center cross-sectional study. Renal failure, 38(3), 442-450.

Rabellino, M., Aragón-Sánchez, J., González, G., Zander, T., Baldi, S., Garcia-Nielsen, L., ... & Maynar, M. (2010). Is endovascular revascularisation worthwhile in diabetic patients with critical limb ischemia who also have end-stage renal disease?. Diabetes research and clinical practice, 90(3), e79-e81.‏

HE, F., Xia, X., Wu, X. F., Yu, X. Q., & Huang, F. X. (2013). Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis.‏

El-Shimi, M. S., El-Farrash, R. A., Ismail, E. A., El-Safty, A., Nada, A. S., El-Gamel, O. A., ... & Shoukry, S. M. (2015). Renal functional and structural integrity in infants with iron deficiency anemia: relation to oxidative stress and response to iron therapy. Pediatric Nephrology, 30(10), 1835-1842.‏

Gürkan, A., Eren, G., Çetinkalp, Ş., Akçay, Y. D., Emingil, G., & Atilla, G. (2016). Monocyte chemotactic protein-1, RANTES and macrophage migration inhibitory factor levels in gingival crevicular fluid of metabolic syndrome patients with gingivitis. Archives of oral biology, 69, 82-88.‏

Motawi, T. K., Shehata, N. I., ElNokeety, M. M., & El-Emady, Y. F. (2018). Potential serum biomarkers for early detection of diabetic nephropathy. diabetes research and clinical practice, 136, 150-158.‏

Giunti, S., Tesch, G. H., Pinach, S., Burt, D. J., Cooper, M. E., Cavallo-Perin, P., ... & Gruden, G. (2008). Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia, 51(1), 198-207.‏

Gao, Y. J., Zhang, L., Samad, O. A., Suter, M. R., Yasuhiko, K., Xu, Z. Z., ... & Ji, R. R. (2009). JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. Journal of Neuroscience, 29(13), 4096-4108.‏

Klöting, N., & Blüher, M. (2014). Adipocyte dysfunction, inflammation and metabolic syndrome. Reviews in Endocrine and Metabolic Disorders, 15(4), 277-287.‏

Zieger, K., Weiner, J., Kunath, A., Gericke, M., Krause, K., Kern, M., ... & Heiker, J. T. (2018). Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet-induced obesity by counteracting adipose tissue inflammation in vivo. Cellular and molecular life sciences, 75(4), 727-742.‏

Roussel, E., Verbiest, A., Milenkovic, U., Van Cleynenbreugel, B., Van Poppel, H., Joniau, S., ... & Albersen, M. (2020). Too good for CARMENA: criteria associated with long systemic therapy free intervals post cytoreductive nephrectomy for metastatic clear cell renal cell carcinoma. Scandinavian Journal of Urology, 54(6), 493-499.‏

Lam, N. N., Lentine, K. L., & Garg, A. X. (2014). End-stage renal disease risk in live kidney donors: what have we learned from two recent studies?. Current opinion in nephrology and hypertension, 23(6), 592.‏

Pippias, M., Kramer, A., Noordzij, M., Afentakis, N., Alonso de la Torre, R., Ambühl, P. M., ... & Stel, V. S. (2017). The European renal association–European dialysis and transplant association registry annual report 2014: a summary. Clinical kidney journal, 10(2), 154-169.‏

Menzies, R. I., Booth, J. W., Mullins, J. J., Bailey, M. A., Tam, F. W., Norman, J. T., & Unwin, R. J. (2017). Hyperglycemia-induced renal P2X7 receptor activation enhances diabetes-related injury. EBioMedicine, 19, 73-83.‏

Yin, J., Gu, L., Wang, Y., Fan, N., Ma, Y., & Peng, Y. (2015). Rapamycin improves palmitate-induced ER stress/NF κ B pathways associated with stimulating autophagy in adipocytes. Mediators of inflammation, 2015.‏

Wang, Y., Zhao, L., Wang, C., Hu, J., Guo, X., Zhang, D., ... & Ji, B. (2017). Protective effect of quercetin and chlorogenic acid, two polyphenols widely present in edible plant varieties, on visible light-induced retinal degeneration in vivo. Journal of Functional Foods, 33, 103-111.‏